Elevated arteriolar adenosine 3',5'-cyclic monophosphate production by SHR.

Area of Science:

• Cardiovascular Physiology
• Molecular Biology
• Pharmacology

Background:

• Hypertension involves complex physiological and morphological changes in the vasculature.
• Cyclic adenosine monophosphate (cAMP) plays a crucial role in regulating vascular tone and function.
• Alterations in cAMP metabolism may contribute to the development and progression of hypertension.

Purpose of the Study:

• To investigate age-related differences in adenosine 3',5'-cyclic monophosphate (cAMP) metabolism in the microcirculation of spontaneously hypertensive rats (SHR) compared to normotensive Wistar-Kyoto (WKY) rats.
• To determine if phosphodiesterase inhibition affects cAMP levels in arterioles during different stages of hypertension.
• To examine the role of beta-adrenergic stimulation on cAMP production in SHR and WKY arterioles.

Main Methods:

• Mesenteric arterioles from SHR and WKY rats (4, 6, 12, 18 weeks old) were incubated in vitro.
• Cyclic adenosine monophosphate (cAMP) levels were measured using radioimmunoassay.
• The effect of the phosphodiesterase inhibitor 1-methyl-3-isobutylxanthine (MIX) and beta-adrenergic agonists (salbutamol, isoproterenol) on cAMP accumulation was assessed.

Main Results:

• Arteriolar cAMP production showed age-dependent patterns in both WKY and SHR rats, with distinct temporal differences.
• At 6 weeks, SHR arterioles exhibited higher cAMP accumulation (with or without MIX) compared to WKY arterioles.
• Beta-adrenergic agonists stimulated cAMP production in a dose-dependent manner in 6-week-old rats, an effect blocked by propranolol; guanosine 3',5'-cyclic monophosphate was not affected.

Conclusions:

• Significant differences in cAMP metabolism are present at the arteriolar level during the developmental phase of spontaneous hypertension.
• These observed alterations in cAMP metabolism may contribute to the observed morphological and physiological changes in SHR during hypertension development.
• The findings highlight the potential involvement of cAMP signaling pathways in the pathophysiology of hypertension.